Antidiabetic Drugs
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Effect of Novel Antidiabetic Drug Combined With Angiotensin Receptor/Neprilysin Inhibitor on Urinary Protein (NCT05922852) | Peking University Third Hospital | 2023-03-01 |
Track Antidiabetic Drugs automatically
Every clearance here is in the API, with alerts when new ones post.